A terrific discussion at @Cognizant Americas Discovery 2026 with @George_Kurtz CEO of @CrowdStrike & @JayZscaler CEO of @zscaler on how the threat landscape is changing with AI and what enterprises need to do to stay ahead of it
Enterprises don't have to choose between moving fast on AI and deploying it safely. The work that makes both possible happens at the point of use: designed orchestration, declared roles, least-privilege access, bounded objectives, and records that can't be rewritten after the fact. We argue in a new piece for @TIME that the economically dominant form of machine intelligence won't be one system that knows everything, but specialized, composable agents, each with a defined role and a small set of tools that belong to one domain.
The talent pyramids are getting broader in the AI era with more talent from undergrad schools, non stem disciplines, internship to full time employment, work-learn-earn apprenticeship templates and mid career shifts
Cognizant Q3’25 results: 5th straight quarter of year-over-year organic growth. Revenue up 7.4% YoY or 6.5% YoY in constant currency, operating margins expanded to 16%, all segments grew organically. Our AI Builder strategy continues gaining traction across productivity, industrialization, and agentification. Grateful to our clients, partners, and especially our associates for driving this momentum.
We announce our 61st US Patent for fine-tuning LLMs. Our latest research, using evolution strategies (ES) for fine-tuning LLMs, has the potential to disrupt the industry. Our approach not only uses less training data than reinforcement learning (RL); it also makes the process more accurate, increasing the quality of work the AI can produce. @Cognizant
Most important “When someone has a large following, use it to leverage scientifically progressive thoughts and information that will help improve collective knowledge instead of airing dogmatic conspiracy drenched views on science and medicine.” @theliverdoc
This is exactly how health and science illiteracy looks like. Blanket statements without objective evidence. Traditional remedies and supplements in the Indian context with proven results do not exist. Zero evidence.
And the bit about "pharma giants and modern medicine" not wanting simple solutions is the biggest absurdity that conspiracy embracing science illiterates promote widely.
From low cost or sometimes free vaccines, highly accessible and cheap antimicrobials and anti inflammatory agents, to cancer curing and genetic disease obliterating gene therapies, modern science and technology has been increasing our life expectancy and pushing limits to ensure people get what they deserve based on evidence and NOT because somebody's grandma, neighbor or ancestors thought so.
It is important to keep traditions and culture alive, I do understand the sentiment, but when it comes to healthcare and medicine, put on your critical thinking cap and try not renting out your brain.
When someone has a large following, use it to leverage scientifically progressive thoughts and information that will help improve collective knowledge instead of airing dogmatic conspiracy drenched views on science and medicine.
I’m pleased to share we made strong strides. We successfully shifted from stabilization to growth, gaining momentum and closing the fourth quarter on a high note in terms of year-over-year revenue growth, large deal signings, and strong bookings. We got to the upper end of our guidance range on revenues, beat margin and EPS expectations for Q4 and 2024.
Our success is driven by our strategy – accelerating growth, becoming an employer of choice, and modernizing our operations. 2024 was a breakthrough year for AI and automation, partnerships, and employee engagement, all while strengthening our business. I believe we’re in a stronger position to seize new growth opportunities ahead.
A special thank you to our clients, partners, and – most of all – our associates for their daily drive to deliver. @Cognizant
Our 3rd quarter results today demonstrated a strong all round performance as we delivered Revenues on the upper end of our guidance range backed by performance on our two largest verticals - Health Sciences and Financial Services. We expanded our operating margin, closed six 100Mn$+ deals and recorded 4th consecutive quarter of EPS growth. Importantly, we advanced our strategic priorities, especially with AI-driven platform investments that are gaining traction with clients and supporting our large deal success.
To our 340K+ associates: Thank you for your outstanding contributions. Together, we’re strengthening our position to seize AI opportunities for ourselves and our clients @Cognizant
.@Cognizant becomes the first global partner to bring workflow data fabric of @ServiceNow to the market. Enhanced integrated data layer powering all workflows and AI agents with real‑time, secure access to data from any source
Last week, we hosted our #CognizantDiscovery2024 conference in London, UK, bringing together industry experts, thought leaders, clients and partners to discover what it means to prepare for an AI-enabled future.
I need to be in the room when India players are doing the calculation on how to get Kohli century when they’re chasing a target of 75 all out against England
Conagra and General Mills reported a slowing of demand in Q2.
Freight cos that haul food have talked about how soft conditions for food & beverage freight have been.
People still gotta eat. What gives?
Pandemic-related SNAP payments ended on March 1.